STEMCELLS, INC.

NASDAQ: STEM
Sarepta Therapeutics and Globalstar are among the companies that punished shareholder the most this past week.
Chris Lange
StemCells just reminded investors and speculators alike just how dangerous it can be to invest in biotech and biohealth companies.
Jon C. Ogg
Wednesday's top analyst calls include Intel, Petrochina, Skullcandy, StemCells, 3D Systems and Rockwell Collins.
Jon C. Ogg
Source: ThinkstockThe war against Alzheimer’s disease is getting another round of stem cell research thrown at it. While this involves a public company, the reality is that Alzheimer’s is truly a...
Jon C. Ogg
Stocks are up Friday, with the Dow Jones Industrial Average up 1.06%, the Nasdaq up 0.74% and the S&P 500 up 0.82%. Friday’s winners include a company beating second-quarter earnings and a biotech...
247sam
Source: Jon OggThese are the top analyst calls of upgrades, downgrades and initiations we have seen from Wall St. research calls this Monday morning.Agrium Inc. (NYSE: AGU) named as Bull of the Day...
Jon C. Ogg
As investors brace for Wednesday’s congressional testimony from Federal Reserve Chairman Ben Bernanke, the stock market is up modestly. The Dow Jones Industrial Average is up 0.38%, the Nasdaq is...
247sam
StemCells, Inc. (NASDAQ: STEM) is seeing a rather favorable reaction to an FDA trial approval today.  The question to ask is if the move is justified.  The exact news is a FDA authorization for...
Jon C. Ogg
There are several stocks trading more heavily than usual this morning, and also experiencing large gains or drops in share prices. These include ISTA Pharmaceuticals Inc. (NASDAQ: ISTA), Morton’s...
Paul Ausick
When you have a credit rating downgrade of the U.S. followed by a 300+ point drop in the DJIA and another near-100 point drop in the NASDAQ, it is no shock at all that you are seeing some big...
Jon C. Ogg
Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there has been on a single day in months and months.  The news is not even on any of the...
Jon C. Ogg
Stem cell stocks are getting hit pretty hard this Tuesday.  On Monday came a ruling from a U.S. district judge which effectively blocks the federal government from funding research which involves...
Jon C. Ogg
Day traders and active traders have many movers this Wednesday morning to choose from.  The top alerts were seen in Symantec Corporation (NASDAQ: SYMC), Check Point Software Technologies Ltd....
Jon C. Ogg
Today’s version of the BioHealth Business Daily is rather different as we have a big disappointment from one of the top biotech operations in the world.  BioHealth stocks moving on news and after...
Jon C. Ogg
We are seeing many key movers in the BioHealth space today.  Biotech stocks and drug stocks are often more volatile than other sectors.  Today’s BioHealth Business Daily includes the key moves...
Jon C. Ogg